Warfarin-induced leukocytoclastic vasculitis: a case report and review of literature
CY Hsu, WS Chen, SH Sung - Internal Medicine, 2012 - jstage.jst.go.jp
Warfarin is widely prescribed for patients with atrial fibrillation. In addition to unexpected
bleeding, allergic skin reaction is one of its uncommon adverse effects. We herein report an …
bleeding, allergic skin reaction is one of its uncommon adverse effects. We herein report an …
Systematic review of warfarin‐induced skin necrosis case reports and secondary analysis of factors associated with mortality
C Morán‐Mariños, R Corcuera‐Ciudad… - … Journal of Clinical …, 2021 - Wiley Online Library
Objective Warfarin‐induced skin necrosis (WSN) is a rare (0.0. 1%‐0.1%) and severe
adverse reaction. The clinical characteristics of this reaction and its mortality rate have not …
adverse reaction. The clinical characteristics of this reaction and its mortality rate have not …
Coagulation disorders and their cutaneous presentations: Pathophysiology
Y Chang, G Dabiri, E Damstetter, EB Ebot… - Journal of the American …, 2016 - Elsevier
Hypercoagulable states are inherited or acquired predispositions to venous or arterial
thromboses that are best understood in the context of the coagulation cascade …
thromboses that are best understood in the context of the coagulation cascade …
A case of leukocytoclastic vasculitis caused by novel anticoagulant rivaroxaban
R Dean, AM Messer, M Pickett… - Dermatology online …, 2017 - escholarship.org
Cutaneous leukocytoclastic vasculitis (LCV) is type of small vessel vasculitis that commonly
presents as palpable purpura involving the lower extremities and buttocks. Approximately …
presents as palpable purpura involving the lower extremities and buttocks. Approximately …
Oral warfarin intake affects skin inflammatory cytokine responses in rats
AP Aleksandrov, I Mirkov, L Zolotarevski… - Environmental …, 2017 - Elsevier
Warfarin is an anticoagulant used in prevention/prophylaxis of thromboembolism. Besides
the effects on coagulation, non-hemorrhagic reactions have also been documented …
the effects on coagulation, non-hemorrhagic reactions have also been documented …
Persistence and discontinuation of oral anticoagulant: remaining issues not addressed by phase III clinical trials
There is general consensus that oral anticoagulant (OAC) therapy is recommended for
stroke prevention in patients with atrial fibrillation (AF) and stroke risk factors. 1–3 It is …
stroke prevention in patients with atrial fibrillation (AF) and stroke risk factors. 1–3 It is …
A necrotic skin lesion in a dialysis patient after the initiation of warfarin therapy: a difficult diagnosis
MA Rockx, MM Sood - Journal of thrombosis and thrombolysis, 2010 - Springer
Necrotic skin lesions are unfortunately common in patients with end stage renal disease
undergoing dialysis therapy. We present a case of a necrotic skin lesion in a peritoneal …
undergoing dialysis therapy. We present a case of a necrotic skin lesion in a peritoneal …
[PDF][PDF] Skin necrosis complicated by warfarin-induced protein S deficiency
TY Liaw, CH Chang - J Formos Med Assoc, 2014 - core.ac.uk
Warfarin is a widely and easily administered oral anticoagulant and becomes the standard
treatment for various thromboembolic events including livedo vasculitis. 1 A healthy 15-year …
treatment for various thromboembolic events including livedo vasculitis. 1 A healthy 15-year …
Protein S deficiency revealed by skin necrosis in a patient with lupus
A Plana-Pla, I Bielsa Marsol, C Ferrandiz Foraster - Lupus, 2019 - journals.sagepub.com
Protein S deficiency is rare in systemic lupus erythematosus (SLE) and is generally
associated with the presence of antiphospholipid (APL) antibodies. Lack of protein S can …
associated with the presence of antiphospholipid (APL) antibodies. Lack of protein S can …